In the published article by Lee JH et al. entitled “Concomitant ultrasound-guided intra-gestational sac methotrexate-potassium chloride and systemic methotrexate injection in the recurrent cesarean scar pregnancy” (Obstet Gynecol Sci 2016;59(3):245-248. doi: http://dx.doi.org/10.5468/ogs.2016.59.3.245), the Figure 2 is given incorrectly. The Editorial Office would like to correct the Figure 2 a...

Background: With an aim to reduce the rates of repeat cesarean section in women with a previous scar, prediction of scar rupture or dehiscence is important. If we could predict the risk of rupture by measuring the scar thickness closer to term, we could pursue a trial of scar safely. Aims: To evaluate the use of ultrasound measured thickness of lower uterine segment as one of the predictors of ...

AIM The study was conducted to illustrate the clinical characteristics and treatment outcomes of patients with persistent cesarean scar pregnancy (PCSP). METHODS During a six-year period, 38 cases of PCSP were diagnosed and treated conservatively to preserve fertility. The clinical presentations, imaging findings and treatment outcomes of these patients were reviewed. RESULTS Fourteen out o...

Myometrial pregnancy developing in a previous caesarean section scar is the rarest of all ectopic pregnancies (EP) and probably one of the most dangerous of all because of the risk of rupture and hemorrhage. The recent recognition of this problem means that diagnosis and management are still in their infancy, and there is no consensus regarding the best management of CSP. Methotrexate (MTX) can...

Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Linkou, Tao-Yuan, Taiwan (Drs. Wang, Chang, Yu). Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Linkou and Chang Gung University of Medicine, Tao-Yuan, Taiwan (Dr. Wang). Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung, Taiwan (Dr. Wu). Department of Obste...